« FDA Approvals - Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year | Main | FDA Approvals - Bausch & Lomb Receives FDA Approval Of Besivance(TM), New Topical »

Mylan Gets Tentative FDA Approval For Singulair (Pharmaceutical Business Review)


Mylan Gets Tentative FDA Approval For Singulair (Pharmaceutical Business Review)
Mylan has declared that it has received tentative approval from FDA for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets. Montelukast Sodium Tablets are the generic version of Merck and Co.'s Singulair, which is used for the treatment of asthma and allergy.
FDA News Search
Breaking FDA Recalls
Breaking FDA Approvals
Health Tip
  • It’s a little known fact that an espresso shot benefits your health in a variety of important ways.
Food & Drug Categories
FDA News Archive
Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources
 

©2006 FDA-News.com. All rights reserved.